- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/48 - Hydrolases (3) acting on peptide bonds (3.4)
Patent holdings for IPC class A61K 38/48
Total number of patents in this class: 4069
10-year publication summary
|
312
|
337
|
375
|
309
|
343
|
305
|
320
|
281
|
249
|
76
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2220 |
136 |
| Ipsen Biopharm Limited | 336 |
76 |
| MERZ PHARMA GmbH & CO. KGaA | 603 |
68 |
| Talengen International Limited | 81 |
62 |
| The Regents of the University of California | 20506 |
42 |
| Revance Therapeutics, Inc. | 126 |
40 |
| Curemark, LLC | 77 |
39 |
| Baxter International Inc. | 1891 |
36 |
| Modernatx, Inc. | 1280 |
36 |
| HANSA Biopharma AB | 75 |
36 |
| Bioverativ Therapeutics Inc. | 214 |
35 |
| The Children's Hospital of Philadelphia | 838 |
33 |
| Translate bio, Inc. | 411 |
33 |
| Baxter Healthcare S.A. | 1387 |
30 |
| Penland Foundation | 39 |
30 |
| Takeda Pharmaceutical Company Limited | 2719 |
27 |
| Omrix Biopharmaceuticals Ltd. | 150 |
26 |
| Talengen Institute of Life Sciences Co., Ltd. | 28 |
25 |
| Endo Biologics Limited | 37 |
25 |
| Alexion Pharmaceuticals, Inc. | 645 |
24 |
| Other owners | 3210 |